3911 - 3920 of 8715 Results
Title
Year
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023OPENTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10853986/pdf/nihms-1931898.pdfCitation Count: 3
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 2
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Best OA location URL: https://doi.org/10.1038/s41467-024-52298-2Citation Count: 4
-
OPENTitle: CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathologyJournal Name: Nature ImmunologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 10Start Page: 1735End Page: 1747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41590-023-01604-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11102766Citation Count: 115
-
OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391001/pdf/jmcp.2021.27.6.785.pdfCitation Count: 10
-
OPENTitle: CD4 + T cells contribute to neurodegeneration in Lewy body dementiaJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6569Start Page: 868End Page: 874Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abf7266Best OA location URL: https://escholarship.org/uc/item/7h341961Citation Count: 172
-
OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 13
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11098594Citation Count: 127
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8486338Citation Count: 26
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 54